An Initial Injection and a Crossover Injection of Amniotic Suspension Allograft Following Failed Treatment with Hyaluronic Acid or Saline Are Equally Effective in the Treatment of Moderate Symptomatic Knee Osteoarthritis Over 12 Months.

[1]  B. Mandelbaum,et al.  Safety and Efficacy of an Amniotic Suspension Allograft Injection over 12 Months in a Single-Blinded, Randomized Controlled Trial for Symptomatic Osteoarthritis of the Knee. , 2021, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[2]  J. Farr,et al.  Amniotic Product Treatments: Clinical and Basic Science Evidence , 2020, Current Reviews in Musculoskeletal Medicine.

[3]  J. Farr,et al.  Amniotic Suspension Allograft Modulates Inflammation in a Rat Pain Model of Osteoarthritis , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  J. Farr,et al.  A Randomized Controlled Single-Blind Study Demonstrating Superiority of Amniotic Suspension Allograft Injection Over Hyaluronic Acid and Saline Control for Modification of Knee Osteoarthritis Symptoms , 2019, The Journal of Knee Surgery.

[5]  Sean Tighe,et al.  Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis: A Prospective, Single-Center Pilot Study , 2019, Pain medicine.

[6]  P. Conaghan,et al.  Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis , 2019, Advances in Therapy.

[7]  K. Paterson,et al.  Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. , 2019, Regenerative medicine.

[8]  F. Vilchez-Cavazos,et al.  Human amniotic membrane intra-articular injection prevents cartilage damage in an osteoarthritis model , 2018, Experimental and therapeutic medicine.

[9]  G. Isbary,et al.  Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  C. T. Vangsness,et al.  The Placenta: Applications in Orthopaedic Sports Medicine , 2018, The American journal of sports medicine.

[11]  Jeremy B. Vines,et al.  Proteomic Comparison of Amnion and Chorion and Evaluation of the Effects of Processing on Placental Membranes. , 2017, Wounds : a compendium of clinical research and practice.

[12]  Jeffrey B. Driban,et al.  Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial , 2017, JAMA.

[13]  G. Guyatt,et al.  Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations , 2017, BMJ Open.

[14]  S. Tseng,et al.  Efficacy of Particulate Amniotic Membrane and Umbilical Cord Tissues in Attenuating Cartilage Destruction in an Osteoarthritis Model. , 2016, Tissue engineering. Part A.

[15]  N. Heckmann,et al.  Application of Amniotic Tissue in Orthopedic Surgery. , 2016, American journal of orthopedics.

[16]  B. Saltzman,et al.  Human Amniotic Membrane–Derived Products in Sports Medicine , 2016, The American journal of sports medicine.

[17]  J. Farr,et al.  Cryopreserved Amniotic Suspension for the Treatment of Knee Osteoarthritis , 2015, Journal of Knee Surgery.

[18]  F. Eckstein,et al.  Contralateral Knee Effect on Self‐Reported Knee‐Specific Function and Global Functional Assessment: Data From the Osteoarthritis Initiative , 2015, Arthritis care & research.

[19]  Dariusz Szukiewicz,et al.  The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis , 2014, Mediators of inflammation.

[20]  R. Guldberg,et al.  Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development , 2014, Arthritis Research & Therapy.

[21]  P. Stratford,et al.  Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. , 2013, Rheumatology.

[22]  K. Landorf,et al.  Minimal Important Difference (MID) of two commonly used outcome measures for foot problems , 2010, Journal of foot and ankle research.

[23]  M. Dougados,et al.  OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. , 2004, Osteoarthritis and cartilage.

[24]  E. Roos,et al.  The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis , 2003, Health and quality of life outcomes.

[25]  P. Bijur,et al.  Prospective validation of clinically important changes in pain severity measured on a visual analog scale. , 2001, Annals of emergency medicine.

[26]  M. Goldring,et al.  Osteoarthritis and cartilage: The role of cytokines , 2000, Current rheumatology reports.

[27]  S. Z. Zhao,et al.  Evaluation of the Functional Status Aspects of Health‐Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib , 1999, Pharmacotherapy.

[28]  J. Kellgren,et al.  Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.